Private Equity
United Claim Solutions, a portfolio company of Great Point Partners, has acquired Portsmouth, Ohio-based Zebu Compliance Solutions, a provider of payment integrity and ongoing credentialing solutions to payors, clearinghouses and provider organizations. No financial terms were disclosed.
3 min read · 25 June 2018
Centauri Health Solutions Inc, which is backed by Silversmith Capital Partners, has acquired NHI Billing Services, a provider of Medicaid-related specialized billing services to hospitals and health systems. No financial terms were disclosed.
4 min read · 25 June 2018
Netgain Technology LLC, which is backed by Bluff Point Associates, has acquired Huntington Beach, California-based iManaged Solutions LLC, a provider of cloud services to optometry practices. No financial terms were disclosed.
3 min read · 25 June 2018
Frazier Healthcare Partners has named Jim Brady as an operating partner on the firm's growth buyout team. Previously, Brady was a healthcare operating partner at Marlin Equity Partners.
2 min read · 25 June 2018
2 min read · 22 June 2018
London-based Autolus, a biopharmaceutical company focused on developing and commercializing T-cell therapies, has raised about $150 million after pricing 8.8 million shares of its IPO at $17 per share. The stock began trading June 22, 2018 on the NASDAQ under the ticker symbol “AUTL.” Goldman Sachs and Jefferies LLC are the lead underwriters. Autolus’pre-IPO backers include Arix Bioscience plc, Cormorant Asset Management, Nextech Invest, Syncona and Woodford Investment Management.
2 min read · 22 June 2018
Chicago-based Xeris Pharmaceuticals Inc, a specialty pharmaceutical company, has raised $85.5 million for its IPO after pricing its 5.7 million shares at $15 per share. The stock began trading June 21, 2018 on the NASDAQ under the ticker symbol "XERS." Jefferies, Leerink Partners, RBC Capital Markets and Mizuho Securities are the lead underwriters. Xeris Pharmaceuticals' pre-IPO backers include Merieux Developpement, Wild Basin Investments, Deerfield, Redmile Group and Texas Venture Labs, according to Crunchbase.
2 min read · 21 June 2018
South San Francisco-based Kezar Life Sciences, a biopharmaceutical company developing novel small molecule therapeutics, has raised about $75 million for its IPO after pricing its 5 million shares at $15 per share. The stock began trading June 21, 2018 on the NASDAQ under the ticker symbol "KZR." Jefferies and Cowen are the lead underwriters. Kezar's pre-IPO backers include Cormorant Asset Management, Morningside Venture, Cowen Healthcare Investments, Pappas Ventures, Qiming Venture Partners, Bay City Capital, EcoR1 Capital, Omega Funds and Aju IB Investment.
3 min read · 21 June 2018
Reshaping the healthcare market, one payer services deal at a time
2 min read · 21 June 2018
Belmont Instrument LLC, which is backed by Audax Private Equity, has acquired MTRE Advanced Technologies Ltd from Mennen Medical Ltd. No financial terms wee disclosed. Based in Yavne, Israel, MTRE is a maker of non-invasive solutions for body temperature management.
3 min read · 20 June 2018
